Stockreport

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

scPharmaceuticals Inc.  (SCPH) 
Last scpharmaceuticals inc. earnings: 3/24 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: scpharmaceuticals.com
PDF FUROSCIX Auto-injector being developed as a complement to the FUROSCIX On-body Infusor Company anticipates topline data in Q3 2024, followed by a Supplemental New Drug [Read more]